CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15284561

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to new crystalline forms of Pitavastatin hemicalcium salt, referred to hereinafter as polymorphic Forms A, B, C, D, E and F, as well as the amorphous form. Furthermore, the present invention is directed to processes for the preparation of these crystalline forms and the amorphous form and pharmaceutical compositions comprising these crystalline forms or the amorphous forms.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NISSAN CHEMICAL INDUSTRIES LTDTOKYO JAPAN TOKYO METROPOLIS

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Blatter, Fritz Reinach, CH 101 634
Schoening, Kai-Uwe Oberwil, CH 28 44
Szelagiewicz, Martin Muenchenstein, CH 69 246
VAN, DER SCHAAF Paul Adriaan Hagenthal-le-Haut, FR 72 634

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation